Navigation Links
Viral curiosity spreads across continents
Date:4/22/2013

WHAT: Biologist Esteban Engel, Ph.D., was named by The Pew Charitable Trusts as the "Biomedical Researcher of the Month," for his innovative work in neurovirologythe study of viruses infecting the nervous system. As a postdoctoral researcher in the Princeton University laboratory of Lynn Enquist, Ph.D., Dr. Engel studies the spread of herpes simplex virus type 1 (HSV-1)which, in rare cases, can lead to blindness or lethal encephalitis.

Dr. Engel's story is part of a "Biomedical Researcher of the Month" series launched by Pew, and is the first to feature a Latin American fellow. Pew's Latin American fellows program gives individuals like Engel, who hails from Chile, an opportunity to further their scientific knowledge by promoting exchange and collaboration between investigators in the United States and Latin America. Since 1991, Pew's biomedical programs have provided funding to more than 200 young scientists from Latin America to receive postdoctoral training in the United States, resulting in advances that span continents.

WHO: Experts are available for interviews regarding Dr. Engel's research and the program:

  • Esteban Engel, Ph.D., postdoctoral fellow, Department of Molecular Biology, Princeton Neuroscience Institute, Princeton University
  • Anita Pepper, Ph.D., director of the Pew Programs in the Biomedical Sciences Pepper is the director of The Pew Charitable Trusts' biomedical programs, which include both the Latin American fellows and the Pew scholars program.

WHERE: Visit http://www.pewhealth.org/other-resource/Interview-with-Pew-Latin-American-Fellow-Esteban-Engel-85899469672 to read the full question-and-answer story, which covers both Dr. Engel's research and his motivation to conduct it in the United States.

CONTACT: Chelsea Toledo at 202-540-6846, ctoledo@pewtrusts.org


'/>"/>

Contact: Chelsea Toledo
ctoledo@pewtrusts.org
202-540-6846
Pew Health Group
Source:Eurekalert

Related biology news :

1. Recreational use of HIV antiretroviral drug linked to its psychoactivity
2. Antiviral lipid earns patent
3. Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens
4. Study: Viral reactivation a likely link between stress and heart disease
5. Protein production: Going viral
6. Viral alliances overcoming plant defenses
7. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
8. The physics of going viral
9. Vitamin D supplements may protect against viral infections during the winter
10. Women & Infants participating in study of treatment of common viral infection in pregnancy
11. Discovery offers insight into treating viral stomach flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 27, 2017 A Europe-wide survey of institutes ... using animals in their research treat them with due care. The ... detailed analysis of the results indicates that there is a strong ... put into practice the principles of the 3Rs (Refine, Reduce, ... What are ...
(Date:2/27/2017)... REDWOOD CITY, Calif. , Feb. 27, 2017 ... specialty pharmaceutical company focused on the development and ... moderate-to-severe acute pain, announced today the U.S. Food ... New Drug Application (NDA) under section 505(b)(2) for ... for the treatment of patients with moderate-to-severe acute ...
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, 2017 /PRNewswire/ ... ) and SELLAS Life Sciences Group , ... immunotherapies, today announced that Advaxis has granted SELLAS ... agent using Advaxis, proprietary Lm -based antigen ... peptide antigen mixture (galinpepimut-S). Advaxis, ...
(Date:2/27/2017)... URBANDALE, Iowa (PRWEB) , ... February 27, 2017 , ... ... is following the advice of his grandfather, “Hire for attitude. Train for skill.” , ... State University star linebacker Jevohn Miller as a salesman. Zamzow is hoping to replicate ...
Breaking Biology Technology: